United States Antimony Corp (UAMY) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has positive analyst ratings and growth in revenue, the recent financial performance, insider selling, and lack of strong trading signals suggest a cautious approach. The technical indicators and options data also do not indicate a compelling entry point.
The MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 43.355, showing no clear overbought or oversold conditions. Moving averages are converging, and the stock is trading near its support level of 8.342, with resistance at 10.748. The stock lacks a strong upward trend.

Analysts have increased price targets recently, citing growth opportunities such as the joint venture with Americas Gold and Silver and prioritization of domestic antimony supply. Revenue growth of 89.63% YoY in Q4 2025 is also a positive indicator.
Insider Gary C. Evans plans to sell $3.92 million worth of shares, which could indicate a lack of confidence in near-term stock performance. Net income and EPS have declined significantly YoY, and geopolitical tensions in the Middle East could create market uncertainty.
In Q4 2025, the company reported an 89.63% YoY increase in revenue, but net income dropped by -67.36% YoY, and EPS fell to 0. Gross margin improved slightly to 20.34%. Overall, the financials show revenue growth but worsening profitability.
Analysts maintain a Buy rating with increased price targets (e.g., $13 from $11 by B. Riley on 2026-03-24). They cite catalysts such as the joint venture, expanded feedstock procurement, and prioritization of domestic supply. However, delays in the Thompson Falls expansion are noted as a short-term concern.